Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Tuna, Musaffe ^a   Ju, Zhenlin ^a   Amos, Christopher I ^a   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acquired uniparental disomy; Soft tissue sarcoma and whole genome

Indexed keywords

ARTICLE; CHROMOSOME TRANSLOCATION; EWING SARCOMA; FIBROSARCOMA; GASTROINTESTINAL STROMAL TUMOR; GENETIC ASSOCIATION; LEIOMYOSARCOMA; LIPOSARCOMA; MYXOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SINGLE NUCLEOTIDE POLYMORPHISM; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; UNIPARENTAL DISOMY;

CENTROMERE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; HOMOZYGOTE; HUMANS; INHERITANCE PATTERNS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOMA; TELOMERE; TRANSLOCATION, GENETIC; UNIPARENTAL DISOMY;

EID: 84870380691     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-60     Document Type: Article

References (37)

1. Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, et al. Nat Med 2010 16 7 781 787 10.1038/nm.2174 20581836
2. Genomic profiling reveals subsets of dedifferentiated liposarcoma to follow separate molecular pathways. Rieker RJ, Weitz J, Lehner B, Egerer G, Mueller A, Kasper B, Schirmacher P, Joos S, Mechtersheimer G, Virchows Arch 2010 456 3 277 285 10.1007/s00428-009-0869-9 20039060
3. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Segal NH, Pavlidis P, Antonescu CR, Maki RG, Noble WS, DeSantis D, Woodruff JM, Lewis JJ, Brennan MF, Houghton AN, et al. Am J Pathol 2003 163 2 691 700 10.1016/S0002-9440(10)63696-6 12875988 (Pubitemid 36909430)
4. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity. White VA, McNeil BK, Thiberville L, Horsman DE, Genes Chromosomes Cancer 1996 15 2 138 143 10.1002/(SICI)1098-2264(199602)15:2<138::AID-GCC10>3.0.CO;2-J 8834179 (Pubitemid 26048416)
5. Soft tissue sarcomas of childhood. Meyer WH, Spunt SL, Cancer Treat Rev 2004 30 3 269 280 10.1016/j.ctrv.2003.11.001 15059650 (Pubitemid 38477272)
6. Molecular classification of soft tissue sarcomas and its clinical applications. Jain S, Xu R, Prieto VG, Lee P, Int J Clin Exp Pathol 2010 3 4 416 428 20490332
7. Lipomatous tumors-how we have reached our present views, what controversies remain and why we still face diagnostic problems: a tribute to Dr Franz Enzinger. Kindblom LG, Adv Anat Pathol 2006 13 6 279 285 10.1097/01.pap.0000213053.00060.5a 17075293 (Pubitemid 44673443)
8. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Horvai AE, DeVries S, Roy R, O'Donnell RJ, Waldman F, Mod Pathol 2009 22 11 1477 1488 10.1038/modpathol.2009.119 19734852
9. Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. Pedeutour F, Suijkerbuijk RF, Van Gaal J, Van de Klundert W, Coindre JM, Van Haelst A, Collin F, Huffermann K, Turc-Carel C, Cancer Genet Cytogenet 1993 66 2 133 134 10.1016/0165-4608(93)90245-H 8500103 (Pubitemid 23155355)
10. Functional copy-number alterations in cancer. Taylor BS, Barretina J, Socci ND, Decarolis P, Ladanyi M, Meyerson M, Singer S, Sander C, PLoS One 2008 3 9 3179 10.1371/journal.pone.0003179 18784837
11. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, et al. Nat Genet 2010 42 8 715 721 10.1038/ng.619 20601955
12. Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome. Mohamedali AM, Smith AE, Gaken J, Lea NC, Mian SA, Westwood NB, Strupp C, Gattermann N, Germing U, Mufti GJ, J Clin Oncol 2009 27 24 4002 4006 10.1200/JCO.2009.22.6985 19528370
13. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ, Lister TA, Young BD, Cancer Res 2005 65 2 375 378 15695375
14. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, Tamura A, Honda H, Sakata-Yanagimoto M, Kumano K, et al. Nature 2009 460 7257 904 908 10.1038/nature08240 19620960
15. UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Szpurka H, Gondek LP, Mohan SR, Hsi ED, Theil KS, Maciejewski JP, Leukemia 2008
16. Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer. Tuna M, Smid M, Zhu D, Martens JW, Amos CI, PLoS One 2010 5 11 15094 10.1371/journal.pone.0015094 21152100
17. Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer. Tuna M, Smid M, Martens JW, Foekens JA, Breast Cancer Res Treat 2011
18. Loss of heterozygosity associated with uniparental disomy in breast carcinoma. Murthy SK, DiFrancesco LM, Ogilvie RT, Demetrick DJ, Mod Pathol 2002 15 12 1241 1250 10.1097/01.MP.0000032535.62750.D1 12481003 (Pubitemid 35462990)
19. Uniparentalism in sporadic colorectal cancer is independent of imprint status, and coordinate for chromosomes 14 and 18. Darbary HK, Dutt SS, Sait SJ, Nowak NJ, Heinaman RE, Stoler DL, Anderson GR, Cancer Genet Cytogenet 2009 189 2 77 86 10.1016/j.cancergencyto.2008.10.011 19215787
20. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms. Johnson JE, Gettings EJ, Schwalm J, Pei J, Testa JR, Litwin S, von Mehren M, Broccoli D, Cancer Res 2007 67 19 9221 9228 10.1158/0008-5472.CAN-07-1133 17909028 (Pubitemid 47535909)
21. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. Astolfi A, Nannini M, Pantaleo MA, Di Battista M, Heinrich MC, Santini D, Catena F, Corless CL, Maleddu A, Saponara M, et al. Lab Invest 2010 90 9 1285 1294 10.1038/labinvest.2010.110 20548289
22. Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Reichek JL, Duan F, Smith LM, Gustafson DM, O'Connor RS, Zhang C, Dunlevy MJ, Gastier-Foster JM, Barr FG, Clin Cancer Res 2011 17 6 1463 1473 10.1158/1078-0432.CCR-10-0091 21220470
23. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Barr FG, Duan F, Smith LM, Gustafson D, Pitts M, Hammond S, Gastier-Foster JM, Genes Chromosomes Cancer 2009 48 8 661 672 10.1002/gcc.20673 19422036
24. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, et al. Cancer Res 2005 65 14 6071 6079 10.1158/0008-5472.CAN- 05-0465 16024607 (Pubitemid 40994391)
25. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, et al. Proc Natl Acad Sci USA 2009 106 12 4834 4839 10.1073/pnas.0806514106 19261849
26. Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues. Kuga D, Mizoguchi M, Guan Y, Hata N, Yoshimoto K, Shono T, Suzuki SO, Kukita Y, Tahira T, Nagata S, et al. Neuro Oncol 2008 10 6 995 1003 10.1215/15228517-2008-064 18697953
27. Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma. Kurashina K, Yamashita Y, Ueno T, Koinuma K, Ohashi J, Horie H, Miyakura Y, Hamada T, Haruta H, Hatanaka H, et al. Cancer Sci 2008 99 9 1835 1840 10.1111/j.1349-7006.2008.00881.x 18564138
28. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, et al. Genes Chromosomes Cancer 2008 47 9 755 765 10.1002/gcc.20577 18506748
29. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Narva E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, et al. Nat Biotechnol 2010 28 4 371 377 10.1038/nbt.1615 20351689
30. PDGFRA activating mutations in gastrointestinal stromal tumors. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, et al. Science 2003 299 5607 708 710 10.1126/science. 1079666 12522257 (Pubitemid 36159485)
31. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al. Science 1998 279 5350 577 580 10.1126/science.279.5350.577 9438854 (Pubitemid 28067289)
32. An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications. Gunawan B, von Heydebreck A, Sander B, Schulten HJ, Haller F, Langer C, Armbrust T, Bollmann M, Gasparov S, Kovac D, et al. J Pathol 2007 211 4 463 470 10.1002/path.2128 17226762 (Pubitemid 46332558)
33. Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement. Ul-Hassan A, Sisley K, Hughes D, Hammond DW, Robinson MH, Reed MW, Int J Exp Pathol 2009 90 5 549 557 10.1111/j.1365-2613.2009.00680.x 19765109
34. Dads and disomy and disease. Little M, Van Heyningen V, Hastie N, Nature 1991 351 6328 609 610 10.1038/351609a0 2052085
35. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Anderson J, Gordon A, McManus A, Shipley J, Pritchard-Jones K, Neoplasia 1999 1 4 340 348 10.1038/sj.neo.7900052 10935489
36. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Casola S, Pedone PV, Cavazzana AO, Basso G, Luksch R, D'Amore ES, Carli M, Bruni CB, Riccio A, Oncogene 1997 14 12 1503 1510 10.1038/sj.onc.1200956 9136994 (Pubitemid 27182440)
37. Molecular biology of rhabdomyosarcoma. Gallego Melcon S, Sanchez de Toledo Codina J, Clin Transl Oncol 2007 9 7 415 419 10.1007/s12094-007-0079-3 17652054